Circulating Omentin-1 Across BMI Categories in Type 2 Diabetes and its Association with Insulin Resistance: A Cross-Sectional Study from South India
Saidaiah Ikkurthi, A. R. Srinivasan, Vaikkakara Suresh, Rajendran Jayanthi, Vidya S. DesaiAbstract
Introduction:
Omentin-1 is an adipocytokine predominantly secreted by visceral adipose tissue and associated with insulin sensitivity. Altered levels of omentin-1 in type 2 diabetes mellitus (T2DM) and obesity denote a potential link with insulin resistance.
Methods:
Two hundred twenty-five adult males with T2DM were segregated into non-obese (
Results:
Obese subjects had higher BMI, waist-to-hip ratio, fasting glucose, HbA1c, fasting insulin, HOMA-IR, lipid fractions, and METS-IR as compared to non-obese. Serum omentin-1 levels declined progressively with increasing adiposity [non-obese 687.6 (654.1–763.2), overweight 587.6 (548.6–658.1), obese 459.3 (398.7–524.8) ng/L;
Conclusion:
Serum omentin-1 shows an inverse association with adiposity, insulin resistance, and lipid parameters in T2DM, suggesting that omentin-1 could serve as a potential marker of an adverse cardiometabolic profile, although comprehensive studies are further warranted.